Discover, develop and commercialise smartpeptide based medicines and diagnostics to treat patients with autoimmune and genetic diseases with the greatest unmet medical needs where current therapies are inadequate.
Contact UsThe ixPeptide® Platform - the breakthrough molecular solution for the custom design of self-assembling polypeptides. It increases the drug-likeness of the peptide molecules and creates first-in-class medicines to treat patients with major unmet clinical needs.
Ladon Therapeutics is a clinical stage biopharmaceutical company. Ladon Therapeutics brings together breakthrough peptide chemistry and a state of the art diagnostic laboratory from gene expression profiling to in vivo disease models to characterize, test and evaluate ixPeptide® drug candidates.
Ladon Therapeutics discovers, develops and commercializes ixPeptide® based first-in-class medicines and diagnostics to treat patients with autoimmune and genetic diseases with major unmet medical needs.
Our vision is to be a pioneering bio-pharmaceutical company that makes breakthrough scientific innovations happen to become cures for debilitating diseases.
Discover and Develop a new generation of smart peptide based therapies
Discover and Develop a new generation of smart peptide based therapies
Discover and Develop a new generation of smart peptide based therapies
Discover and Develop a new generation of smart peptide based therapies
The ixPeptide® Platform is a breakthrough molecular solution to increase the “druggability” potential of peptidic compounds.Pharmacologically active peptides are a unique class of compounds with molecular weights from 300 to 5000 Da.They are considered as linear polymers of natural and/or artificial amino acids.